Basic Information
RNALocate ID: | RLID:11004135 |
RNA Symbol: | hsa-miR-744-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-744-5p |
RNA ID: | miRBase:MIMAT0004945 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002696 | Cytoplasm | Neural progenitor cells | 21363885 |
RLID:01002697 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002698 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002699 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002700 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11004134 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11004136 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11004137 | Exosome | K562 cells | 24460325 |
RLID:11004138 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11004139 | Microvesicle | Plasma | 23077538 |
RLID:11004140 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000216 | Exosome | Blood|Endothelial cells | |
RLID-D:11000721 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-744-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-68635 |
MNDR | hsa-miR-744-5p | Lymphoma | MNDR-E-MI-68636 |
MNDR | hsa-miR-744-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-68637 |
MNDR | hsa-miR-744-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-68638 |
MNDR | hsa-miR-744-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-68639 |
MNDR | hsa-miR-744-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-68640 |
MNDR | hsa-miR-744-5p | Her2-receptor positive breast cancer | MNDR-E-MI-68641 |
MNDR | hsa-miR-744-5p | Breast cancer luminal | MNDR-E-MI-68642 |
MNDR | hsa-miR-744-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-68643 |
MNDR | hsa-miR-744-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-68644 |
MNDR | hsa-miR-744-5p | Gastric cancer | MNDR-E-MI-68645 |
MNDR | hsa-miR-744-5p | Alzheimer disease | MNDR-E-MI-68646 |
MNDR | hsa-miR-744-5p | Bladder cancer | MNDR-E-MI-68647 |
MNDR | hsa-miR-744-5p | Dysautonomia familial | MNDR-E-MI-68648 |
MNDR | hsa-miR-744-5p | Leukemia | MNDR-E-MI-68649 |
MNDR | hsa-miR-744-5p | Cardiovascular disease | MNDR-E-MI-68650 |
MNDR | hsa-miR-744-5p | Carotid stenosis | MNDR-E-MI-68651 |
MNDR | hsa-miR-744-5p | Lung cancer | MNDR-E-MI-68652 |
MNDR | hsa-miR-744-5p | Parkinson disease | MNDR-E-MI-68653 |
MNDR | hsa-miR-744-5p | Basal-like breast cancer | MNDR-E-MI-68654 |
MNDR | hsa-miR-744-5p | Pituitary neoplasms | MNDR-E-MI-68655 |
MNDR | hsa-miR-744-5p | Pancreatic cancer | MNDR-E-MI-68656 |
MNDR | hsa-miR-744-5p | Williams syndrome | MNDR-E-MI-68657 |
MNDR | hsa-miR-744-5p | Rectum adenocarcinoma | MNDR-E-MI-68658 |
MNDR | hsa-miR-744-5p | Colon cancer | MNDR-E-MI-68659 |
MNDR | hsa-miR-744-5p | Colon adenocarcinoma | MNDR-E-MI-68660 |
MNDR | hsa-miR-744-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-68661 |
MNDR | hsa-miR-744-5p | Acromegaly | MNDR-E-MI-68662 |
MNDR | hsa-miR-744-5p | Glioblastoma | MNDR-E-MI-68663 |
MNDR | hsa-miR-744-5p | Glioma | MNDR-E-MI-68664 |
MNDR | hsa-miR-744-5p | Chordoma | MNDR-E-MI-68665 |
MNDR | hsa-miR-744-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-68666 |
MNDR | hsa-miR-744-5p | Osteosarcoma | MNDR-E-MI-68667 |
MNDR | hsa-miR-744-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-68668 |
MNDR | hsa-miR-744-5p | Liver cancer | MNDR-E-MI-68669 |
MNDR | hsa-miR-744-5p | Gastric adenocarcinoma | MNDR-E-MI-68670 |
MNDR | hsa-miR-744-5p | Pituitary adenoma | MNDR-E-MI-68671 |
MNDR | hsa-miR-744-5p | Lung adenocarcinoma | MNDR-E-MI-68672 |
MNDR | hsa-miR-744-5p | Thyroid carcinoma | MNDR-E-MI-68673 |
MNDR | hsa-miR-744-5p | Pancreatic adenocarcinoma | MNDR-E-MI-68674 |
MNDR | hsa-miR-744-5p | Carcinoma renal cell | MNDR-E-MI-68675 |
MNDR | hsa-miR-744-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-68676 |
MNDR | hsa-miR-744-5p | Clear cell renal cell carcinoma | MNDR-E-MI-68677 |
MNDR | hsa-miR-744-5p | Biliary tract cancer | MNDR-E-MI-68678 |
MNDR | hsa-miR-744-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-68679 |
MNDR | hsa-miR-744-5p | Esophageal cancer | MNDR-E-MI-68680 |
MNDR | hsa-miR-744-5p | T acute lymphoblastic leukemia | MNDR-E-MI-68681 |
MNDR | hsa-miR-744-5p | Acute t cell leukemia | MNDR-E-MI-68682 |
MNDR | hsa-miR-744-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-68683 |
MNDR | hsa-miR-744-5p | Fibromyalgia | MNDR-E-MI-68684 |
MNDR | hsa-miR-744-5p | Adenoma | MNDR-E-MI-68685 |
MNDR | hsa-miR-744-5p | Hepatocellular carcinoma | MNDR-E-MI-68686 |
MNDR | hsa-miR-744-5p | Rheumatoid arthritis | MNDR-E-MI-68687 |
MNDR | hsa-miR-744-5p | Barrett's adenocarcinoma | MNDR-E-MI-68688 |
MNDR | hsa-miR-744-5p | Hodgkin lymphoma | MNDR-E-MI-68689 |
MNDR | hsa-miR-744-5p | Neuromyelitis optica | MNDR-E-MI-68690 |
MNDR | hsa-miR-744-5p | Colorectal cancer | MNDR-E-MI-68691 |
MNDR | hsa-miR-744-5p | Nasopharynx carcinoma | MNDR-E-MI-68692 |
MNDR | hsa-miR-744-5p | Multiple myeloma | MNDR-E-MI-68693 |
MNDR | hsa-miR-744-5p | Nasopharyngeal cancer | MNDR-E-MI-68694 |
MNDR | hsa-miR-744-5p | Epstein-barr virus infections | MNDR-E-MI-68695 |
MNDR | hsa-miR-744-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-68696 |
MNDR | hsa-miR-744-5p | Stroke lacunar | MNDR-E-MI-68697 |
MNDR | hsa-miR-744-5p | Barrett's carcinogenesis | MNDR-E-MI-68698 |
MNDR | hsa-miR-744-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-68699 |
MNDR | hsa-miR-744-5p | Tubulovillous adenoma | MNDR-E-MI-68700 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ARHGAP5 | Homo sapiens | RR00122473 |
TOP